<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Immunology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Immunology</journal-title><trans-title-group xml:lang="ru"><trans-title>Russian Journal of Immunology</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1028-7221</issn><issn publication-format="electronic">2782-7291</issn><publisher><publisher-name xml:lang="en">Russian Society of Immunology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">889</article-id><article-id pub-id-type="doi">10.31857/S102872210002405-0</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">CD57 expression by peripheral blood cytotoxic T cells in sarcoidosis</article-title><trans-title-group xml:lang="ru"><trans-title>Особенности экспрессии CD57 цитотоксическими Т-лимфоцитами при саркоидозе</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kudryavtsev</surname><given-names>I. .</given-names></name><name xml:lang="ru"><surname>Кудрявцев</surname><given-names>И. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lazareva</surname><given-names>N. .</given-names></name><name xml:lang="ru"><surname>Лазарева</surname><given-names>Н. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Baranova</surname><given-names>O. .</given-names></name><name xml:lang="ru"><surname>Баранова</surname><given-names>О. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Serebriakova</surname><given-names>M. .</given-names></name><name xml:lang="ru"><surname>Серебрякова</surname><given-names>М. К.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ses’</surname><given-names>T. .</given-names></name><name xml:lang="ru"><surname>Сесь</surname><given-names>Т. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff7"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ilkovich</surname><given-names>M. .</given-names></name><name xml:lang="ru"><surname>Илькович</surname><given-names>М. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Totolyan</surname><given-names>A. .</given-names></name><name xml:lang="ru"><surname>Тотолян</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff8"/><xref ref-type="aff" rid="aff9"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Academician I. P. Pavlov First St. Petersburg State Medical University</institution></aff><aff><institution xml:lang="ru">Институт экспериментальной медицины</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Institute of Experimental Medicine</institution></aff><aff><institution xml:lang="ru">Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Academician I.P. Pavlov First St. Petersburg State Medical University</institution></aff><aff><institution xml:lang="ru">Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="ru">Государственный научно-исследовательский институт особо чистых биопрепаратов</institution></aff><aff><institution xml:lang="en">Academician I.P. Pavlov First St. Petersburg State Medical University</institution></aff></aff-alternatives><aff-alternatives id="aff5"><aff><institution xml:lang="ru">Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова</institution></aff><aff><institution xml:lang="en">Institute of Experimental Medicine</institution></aff></aff-alternatives><aff-alternatives id="aff6"><aff><institution xml:lang="ru">Институт экспериментальной медицины</institution></aff><aff><institution xml:lang="en">Academician I.P. Pavlov First St. Petersburg State Medical University</institution></aff></aff-alternatives><aff-alternatives id="aff7"><aff><institution xml:lang="en">State Research Institute of Highly Pure Biopreparations</institution></aff><aff><institution xml:lang="ru">Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова</institution></aff></aff-alternatives><aff-alternatives id="aff8"><aff><institution xml:lang="en">St. Petersburg Pasteur Institute,</institution></aff><aff><institution xml:lang="ru">Институт экспериментальной медицины</institution></aff></aff-alternatives><aff id="aff9"><institution>Научно-исследовательский институт эпидемиологии и микробиологии имени Пастера</institution></aff><pub-date date-type="pub" iso-8601-date="2018-07-15" publication-format="electronic"><day>15</day><month>07</month><year>2018</year></pub-date><volume>21</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>329</fpage><lpage>334</lpage><history><date date-type="received" iso-8601-date="2020-10-22"><day>22</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Kudryavtsev I..., Lazareva N..., Baranova O..., Serebriakova M..., Ses’ T..., Ilkovich M..., Totolyan A...</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Кудрявцев И.В., Лазарева Н.М., Баранова О.П., Серебрякова М.К., Сесь Т.П., Илькович М.М., Тотолян А.А.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Kudryavtsev I..., Lazareva N..., Baranova O..., Serebriakova M..., Ses’ T..., Ilkovich M..., Totolyan A...</copyright-holder><copyright-holder xml:lang="ru">Кудрявцев И.В., Лазарева Н.М., Баранова О.П., Серебрякова М.К., Сесь Т.П., Илькович М.М., Тотолян А.А.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://rusimmun.ru/jour/article/view/889">https://rusimmun.ru/jour/article/view/889</self-uri><abstract xml:lang="en"><p>Using 10-color fl ow cytometry we characterized cytotoxic T cell subsets based on expression of CD45RA, CD62L, CD27, and CD28 and compared the expression of CD57 between these subsets in peripheral blood sample from patients with chronic sarcoidosis (n=46) and healthy volunteers (n=46). Circulating naive, central and eff ector memory as well as TEMRA CD3+CD8+ cells of sarcoidosis patients contained signifi cantly increased proportions CD57+ cells when compared with healthy controls. Interestingly, CD57 expression was increased in subsets with ‘non mature’ and intermediate phenotypes – EM1, EM2, EM4, pE1 and pE2. Our results indicate the involvement of CD3+CD8+ in maintenance in sarcoidosis as well as suggest CD57-positive cells to be the novel target for evaluation the eff ectiveness of sarcoidosis therapy.</p></abstract><trans-abstract xml:lang="ru"><p>С применением многоцветной проточной цитометрии на основании CD45RA, CD62L, CD27 и CD28 у больных хроническим саркоидозом (n=46) и условно здоровых добровольцев (n=46) проведена оценка экспрессии CD57 основными популяциями цитотоксических Т-лимфоцитов периферической крови. Показано, что уровень CD57 был достоверно выше на «наивных» клетках, клетках центральной и эффекторной памяти, а также зрелых эффекторных лимфоцитах популяции TEMRA. Следует отметить, что увеличение CD57+ клеток было характерно как для «не зрелых», так и для «переходных» популяций – EM1, EM2, EM4, pE1 и pE2 – CD3+CD8+ лимфоцитов больных. Полученные результаты указывают на участие цитотоксических Т-лимфоцитов в патогенезе саркоидоза, а также позволяют использовать CD57+ клетки в качестве нового маркера для оценки эффективности лечения данного заболевания.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>sarcoidosis</kwd><kwd>cytotoxic T cells</kwd><kwd>CD57 expression</kwd><kwd>fl ow cytometry</kwd><kwd>саркоидоз</kwd><kwd>цитотоксические Т-лимфоциты</kwd><kwd>экспрессия CD57</kwd><kwd>проточная цитометрия</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Баранова О. П., Илькович М. М., Сперанская А. А. Трудности диагностики саркоидоза органов ды- хания. Практическая медицина 2011, 3(51), 58–62. [Baranova O. P., Ilkovich M. M., Speranskaya A. A. Diffi culties in the diagnosis of sarcoidosis of the respiratory organs. Practical medicine 2011, 3(51), 58–92].</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Georas S. N., Chapman T. J., Crouser E. D. Sarcoidosis and T-helper cells. Th1, Th17, or Th17.1? Am. J. Respir. Crit. Care Med. 2016, 193, 11, 1198–200.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Miedema J. R., Kaiser Y., Broos C. E., W? senbeek M. S., Grunewald J., Kool M. Th17-lineage cells in pulmonary sarcoidosis and Lofgren’s syndrome: Friend or foe? J Autoimmun. 2018, 87, 82–96.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Morais A., Alves H., Lima B., Delgado L., Goncalves R., Tafulo S. HLA class I and II and TNF-alpha gene polymorphisms in sarcoidosis patients. Rev Port Pneumol. 2008, 14(6), 727–146.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Petursdottir D., Haraldsdottir S. O., Bjarnadottir K., Jonsson T., Gislason T., Gudmundsson S., Gudbjornsson B. Sarcoid arthropathy and the association with the human leukocyte antigen. The Icelandic Sarcoidosis Study. Clin Exp Rheumatol. 2013, 31 (5), 711–716.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Prasse A., Georges C. G., Biller H., Hamm H., Matthys H., Luttmann W., Virchow J. C. Jr. Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells. Clin Exp Immunol. 2000, 122(2), 241–248.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Cinetto F., Agostini C. Advances in understanding the immunopathology of sarcoidosis and implications on therapy. Expert Rev Clin Immunol. 2016, 12, 9, 973– 988.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Planck A., Katchar K., Eklund A., Gripenb?ack S., Grunewald J. T-lymphocyte activity in HLA-DR17 positive patients with active and clinically recovered sarcoidosis. Sarcoidosis Vasculitis and Diff use Lung Diseases 2003, 20, 2, 110–117.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Хайдуков С. В., Байдун Л. А., Зурочка А. В., Тотолян А. А. Стандартизованная технология «исследование субпопуляционного состава лимфоцитов периферической крови с применением проточных цитофлюориметров-анализаторов» (проект). Медицинская иммунология 2012, 14 (3), 255–268. [Khaydukov S., Baidun L., Zurochka A., Totolyan A. Methods. Medical Immunology (Russia) 2012, 14 (3), 255–268].</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Кудрявцев И. В., Борисов А. Г., Волков А. Е., Савченко А. А., Серебрякова М. К., Полевщиков А. В. Анализ уровня экспрессии CD56 и CD57 цитотоксическими Т-лимфоцитами различного уровня дифференцировки. Тихоокеанский медицинский журнал 2015, 2(60), 30–35. [Kudryavtsev I. V., Borisov A. G., Volkov A. E., Savchenko A. A., Serebryakova M. K., Polevschikov A. V. CD56 and CD57 expression by distinct populations of human cytotoxic T lymphocytes. Pacifi c Medical Journal 2015, 2 (60), 30–35.].</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Кудрявцев И. В., Борисов А. Г., Васильева Е. В., Кробинец И. И., Савченко А. А., Серебрякова М. К., Тотолян Арег А. Фенотипическая характеристика цитотоксических Т-лимфоцитов: регуляторные и эффекторные молекулы. Медицинская иммунология 2018, 20 (2), 227–240. [Kudryavtsev I. V., Borisov A. G., Vasilyeva E. V., Krobinets I. I., Savchenko A. A., Serebriakova M. K., Totolian Areg A. Phenotypic characterisation of peripheral blood cytotoxic T lymphocytes: regulatory and eff ector molecules. Medical Immunology (Russia) 2018, 20 (2), 227–240].</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Monteiro J., Batliwalla F., Ostrer H., Gregersen P. K. Shortened telomeres in clonally expanded CD28– CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. J. Immunol. 1996, 156 (10), 3587–3590.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Brenchley J. M., Karandikar N. J., Betts M. R., Ambrozak D. R., Hill B. J., Crotty L. E., Casazza J. P., Kuruppu J., Migueles S. A., Connors M., Roederer M., Douek D. C., Koup R. A. Expression of CD57 defi nes replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 2003, 101 (7), 2711–2720.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Le Priol Y., Puthier D., Lecureuil C., Combadiere C., Debre P., Nguyen C., Combadiere B. High cytotoxic and specifi c migratory potencies of senescent CD8+ CD57+ cells in HIV-infected and uninfected individuals. J. Immunol. 2006, 177(8), 5145–5154.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Inokuma M. S., Maino V. C., Bagwell C. B. Probability state modeling of memory CD8+ T-cell diff erentiation. J. Immunol. Methods 2013, 397(1–2), 8–17.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Кудрявцев И. В. Т-клетки памяти: основные по- пуляции и стадии дифференцировки. Российский иммунологический журнал. 2014, 8, 4 (17), 947– 964. [Kudryavtsev I. V. Memory T cells: major populations and stages of diff erentiation. Russian Journal of Immunology. 2014, 8, 4 (17), 947–964].</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Parasa V. R., Forsslund H., Enger T., Lorenz D., Kullberg S., Eklund A., Skold M., Wahlstrom J., Grunewald J., Brighenti S. Enhanced CD8+ cytolytic T cell responses in the peripheral circulation of patients with sarcoidosis and non-Lofgren’s disease. Respir Med. 2018, 138, 38–44.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Imberti L., Sottini A., Signorini S., Gorla R., Primi D. Oligoclonal CD4+ CD57+ T-cell expansions contribute</mixed-citation></ref></ref-list></back></article>
